Malifutai

吗利福肽

Report date: 2023/09/20 20:05:32
NME

Base Information

Drug NameMalifutai
Drug Alias NameBJY-801
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionNitric-oxide synthase, endothelial inhibitorsElongation factor 1-alpha 1 inhibitors
TargetsNitric-oxide synthase, endothelialElongation factor 1-alpha 1
Therapy Area/IndicationsIschemic Stroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGuangdong 8plus1 Medicine Co LtdSecond Military Medical University Of Chinese People'S Liberation Army
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesSecond Military Medical University Of Chinese People'S Liberation ArmyGuangdong 8plus1 Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsIschemic Stroke
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A